Dynamic capabilities of biologics firms in the emerging business market: Perspective of dynamic capabilities evident

Abstract

The biologics industry constitutes an emerging business market, and the innovative and complex tacit knowledge of this market is understood by very few networked actors. In particular, information related to the resources and capabilities of biologics firms is considered highly confidential and is not accessible to the public. This study investigated five of the top ten biologics firms in the Asia–Pacific region. The firms were examined from the `perspective of dynamic capabilities. More specifically, the dynamic capabilities of the firms were explored using a four-stage coding analysis based on grounded theory. A theoretical framework and relevant concepts and theoretical propositions were developed in this study. Thus, this study proposes a conceptual framework that consists of uncommon knowledge, knowledge network, interaction factors, and mobility capability and describes five theoretical propositions and their influence on market competitiveness. This study found that the complex and dynamic market environment in question is driven by dynamic relations among various interaction factors.